Alyeska Investment Group’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Alyeska Investment Group’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-502,849	Closed	-$15.2M	–	585
2016 Q2	$15.2M	Buy	+502,849	New	+$10.2M	0.14%	217

Alyeska Investment Group's CPXX Position: Q3 2016 in Review

Alyeska Investment Group sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 502,849 shares — an estimated $15.2M sold.

Alyeska Investment Group first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $15.2M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

Alyeska Investment Group reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Alyeska Investment Group sold 502,849 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $15.2M.
Alyeska Investment Group first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
Alyeska Investment Group's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $15.2M in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Alyeska Investment Group's 13F filing for Q3 2016, filed 14 Nov 2016.